Get Started

Artificial Intelligence Vigil Neuroscience | Microglia-Focused Therapeutics Company

Enterprise, Biotechnology, Healthcare, Pharmaceuticals, Drug Discovery, Therapeutic, Neuroscience Cambridge , MA, United States

Artificial Intelligence

Vigil Neuroscience | Microglia-Focused Therapeutics Company

Biotechnology, Healthcare, Pharmaceuticals, Drug Discovery, Therapeutic, Neuroscience

Cambridge , MA, United States

Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Our purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. We are utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and their families.

Total Funding: $161 M

Funding Stage: Series B

Business Stage: Scaling Up

Market: B2B

Company Size: 26 to 50

Founded: 2020

Date

Round

$ Raised

Investors

08/24/2021

Series B

$90M

Vida Ventures, Rock Springs Capital, Pivotal bioVenture Partners, OrbiMed, Northpond Ventures, Logos Capital, Lightstone Ventures, Invus, Hatteras Venture Partners, Deep Track Capital, Cormorant Asset Management, Atlas Venture

Date : 08/24/2021

Round: Series B

$ Raised: $90M

Investors: Vida Ventures, Rock Springs Capital, Pivotal bioVenture Partners, OrbiMed, Northpond Ventures, Logos Capital, Lightstone Ventures, Invus, Hatteras Venture Partners, Deep Track Capital, Cormorant Asset Management, Atlas Venture

For AI/ML Startup Founders

Get introduced to VC/PE/CVC investors

Signup and Get Started

For Investors at VC/PE firms

Get introduced to AI/ML Startup founders or founders at Vigil Neuroscience